J Biol Chem, Vol. 274, Issue 32, 22739-22746, August 6, 1999
Molecular Cloning and Characterization of a Channel-like
Transporter Mediating Intestinal Calcium Absorption*
Ji-Bin
Peng
§¶,
Xing-Zhen
Chen
§
,
Urs V.
Berger
§,
Peter M.
Vassilev
**,
Hiroyasu
Tsukaguchi
§,
Edward M.
Brown
**, and
Matthias A.
Hediger
§
From the
Membrane Biology Program and the
§ Renal and ** Endocrine-Hypertension Divisions, Department
of Medicine, Brigham and Women's Hospital and Harvard Medical School,
Boston, Massachusetts 02115
 |
ABSTRACT |
Calcium is a major component of
the mineral phase of bone and serves as a key intracellular second
messenger. Postnatally, all bodily calcium must be absorbed from the
diet through the intestine. Here we report the properties of a calcium
transport protein (CaT1) cloned from rat duodenum using an expression
cloning strategy in Xenopus laevis oocytes, which likely
plays a key role in the intestinal uptake of calcium. CaT1 shows
homology (75% amino acid sequence identity) to the apical calcium
channel ECaC recently cloned from vitamin D-responsive cells of rabbit
kidney and is structurally related to the capsaicin receptor and the TRP family of ion channels. Based on Northern analysis of rat tissues,
a 3-kilobase CaT1 transcript is present in rat duodenum, proximal
jejunum, cecum, and colon, and a 6.5-kilobase transcript is present in
brain, thymus, and adrenal gland. In situ hybridization revealed strong CaT1 mRNA expression in enterocytes of duodenum, proximal jejunum, and cecum. No signals were detected in kidney, heart,
liver, lung, spleen, and skeletal muscle. When expressed in
Xenopus oocytes, CaT1 mediates saturable Ca2+
uptake with a Michaelis constant of 0.44 mM. Transport of
Ca2+ by CaT1 is electrogenic,
voltage-dependent, and exhibits a charge/Ca2+
uptake ratio close to 2:1, indicating that CaT1-mediated
Ca2+ influx is not coupled to other ions. CaT1 activity is
pH-sensitive, exhibiting significant inhibition by low pH. CaT1 is also
permeant to Sr2+ and Ba2+ (but not
Mg2+), although the currents evoked by Sr2+ and
Ba2+ are much smaller than those evoked by
Ca2+. The trivalent cations Gd3+ and
La3+ and the divalent cations Cu2+,
Pb2+, Cd2+, Co2+, and
Ni2+ (each at 100 µM) do not evoke currents
themselves, but inhibit CaT1-mediated Ca2+ transport.
Fe3+, Fe2+, Mn2+, and
Zn2+ have no significant effects at 100 µM on
CaT1-mediated Ca2+ transport. CaT1 mRNA levels are not
responsive to 1,25-dihydroxyvitamin D3 administration
or to calcium deficiency. Our studies strongly suggest that CaT1
provides the principal mechanism for Ca2+ entry into
enterocytes as part of the transcellular pathway of calcium absorption
in the intestine.
 |
INTRODUCTION |
Calcium is the most abundant cation and the fifth most common
inorganic element in the human body. It is a well known first and
second messenger in signal transduction and an essential component of
bone mineral (1, 2). Calcium homeostasis in blood and other
extracellular fluids is tightly controlled through the actions of
calciotropic hormones on bone, kidneys, and intestine (2). The
availability of dietary calcium is a critical determinant of calcium
homeostasis (3). In humans, dietary intake of calcium approximates
500-1000 mg/day, and obligatory endogenous losses in stool and urine
total ~250 mg/day. On the order of 30% of calcium in the diet must
be absorbed to sustain bone growth in children and to prevent
postmenopausal bone loss in aging women (2, 4). To meet the body's
need for calcium, the intestines of most vertebrates evolved
specialized vitamin D-dependent and -independent mechanisms
for ensuring adequate intestinal calcium uptake. Intestinal absorption
of Ca2+ occurs by a saturable, transcellular process and a
nonsaturable, paracellular pathway (5). When dietary calcium is
abundant, the passive paracellular pathway is thought to be
predominant. In contrast, when dietary calcium is limited, the active,
vitamin D-dependent transcellular pathway plays a major
role in calcium absorption (5-7). The transcellular pathway is a
multistep process, consisting of entry of luminal Ca2+ into
the enterocyte and translocation of Ca2+ from its point of
entry (the microvillus border of the apical plasma membrane) to the
basolateral membrane, followed by active extrusion from the cell
(8-10). Intracellular Ca2+ diffusion is thought to be
facilitated by a calcium-binding protein, calbindin D9K
(11), whose biosynthesis is dependent on vitamin D (12). The extrusion
of Ca2+ takes place against an electrochemical gradient and
is mainly mediated by Ca-ATPase (13, 14). The entry of Ca2+
across the apical membrane of the enterocyte is strongly favored electrochemically because the concentration of Ca2+ within
the cell (10
7 to 10
6 M) is
considerably lower than that in the intestinal lumen (10
3
M), and the cell is electronegative relative to the
intestinal lumen (15). Therefore, the movement of Ca2+
across the apical membrane does not require the expenditure of energy
(10, 16). However, it has been controversial as to whether a
transporter or a channel is responsible for this process, although
previous studies indicated that Ca2+ entry is
voltage-independent and largely insensitive to classic L-type calcium
channel blockers (17, 18).
A more detailed understanding of the mechanisms underlying the
transcellular calcium absorptive pathway requires the cloning of the
gene(s) encoding the relevant calcium carrier(s). To achieve this goal,
we took advantage of an expression cloning strategy by using
Xenopus laevis oocytes as the expression system (19). Functional screening of a rat duodenal library by measuring
45Ca2+ uptake resulted in the isolation of a
cDNA clone encoding a calcium transport protein (CaT1).
Interestingly, CaT1 is structurally related to the recently reported
renal apical calcium channel ECaC (20). Our data indicate that CaT1
plays a key role in mediating Ca2+ entry into the
enterocytes as the first step of transcellular intestinal calcium absorption.
 |
EXPERIMENTAL PROCEDURES |
45Ca2+ Uptake Assay--
Defolliculated
X. laevis oocytes were injected with 50 nl of either water
or RNA. 45Ca2+ uptake was assayed 3 days after
injection of poly(A)+ or 1-3 days after injection of
synthetic cRNA. For expression cloning, oocytes were incubated in
modified Barth's solution (19) supplemented with 1 mM
SrCl2 (to avoid excessive loading of oocytes with
Ca2+) as well as penicillin, streptomycin, and gentamycin
at 1 mg/ml. Standard uptake solution contained the following
components: 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2
(including 45Ca2+, NEN Life Science Products),
and 10 mM Hepes, pH 7.5. Uptake was performed at room
temperature for 30 min (for the expression cloning procedure, 2-h
uptakes were employed), and oocytes were washed six times with ice-cold
uptake solution plus 20 mM MgCl2. The effects
of capsaicin or L-type channel blockers on Ca2+ uptake were
studied in uptake solution by addition of 50 µM capsaicin (in ethanol solution, 0.05% final concentration) or 10-100
µM calcium channel blockers in water (nifedipine was
diluted with uptake solution from 100 mM Me2SO
stock solution). Control experiments were performed with the
appropriate ethanol and Me2SO concentrations. Unless stated
specifically, data are presented as means obtained from at least three
experiments with 7-10 oocytes/group with S.E. as the index of
dispersion. Statistical significance was defined as having a
p value of <0.05 as determined by Student's t test.
Expression Cloning--
Expression cloning using
Xenopus oocytes was performed essentially as described (19).
Briefly, duodenal poly(A)+ RNA from rats fed a
calcium-deficient diet (ICN Pharmaceuticals, Inc., Costa Mesa, CA) for
2 weeks was size-fractionated. A cDNA library was then constructed
from the fractions of 2.5-3 kilobases (kb)1 that stimulated
45Ca2+ uptake activity when expressed in
oocytes. The RNAs synthesized in vitro from pools of ~500
clones were injected into oocytes, and the abilities of the pools to
stimulate Ca2+ uptake were assayed. A positive pool was
sequentially subdivided and assayed in the same manner until a single
clone was obtained. The cDNA clone was sequenced bidirectionally in
the W. M. Keck facility at Yale University.
Northern Analysis--
Poly(A)+ RNA (3 µg) from
rat tissues was electrophoresed in formaldehyde-agarose gels and
transferred to nitrocellulose membranes. The filters were probed with
32P-labeled full-length CaT1 cDNA; hybridized at
42 °C with a solution containing 50% formamide, 5× saline/sodium
phosphate/EDTA, 2× Denhardt's solution, 0.1% SDS, and 100 µg/ml
denatured salmon sperm DNA; and washed with 5× SSC and 0.1% SDS at
50 °C for 2 × 30 min and with 0.1× SSC at 65 °C for 3 × 30 min. Autoradiography was performed at
80 °C for 1-2 days.
In Situ Hybridization--
Digoxigenin-labeled sense and
antisense runoff transcripts were synthesized using the Genius kit
(Roche Molecular Biochemicals). CaT1 cRNA probes were transcribed from
a polymerase chain reaction fragment that contains ~2.7 kb of CaT1
cDNA (nucleotides 126-2894) flanked at either end by promoter
sequences for SP6 and T7 RNA polymerases. Sense and antisense
transcripts were alkali-hydrolyzed to an average length of 200-400
nucleotides. In situ hybridization was performed on 10-µm
cryosections of fresh-frozen rat tissues. Sections were immersed in
slide mailers in hybridization solution composed of 50% formamide, 5×
SSC, 2% blocking reagent (Roche Molecular Biochemicals), 0.02% SDS,
and 0.1% N-lauroylsarcosine and hybridized at 68 °C for
16 h with sense or antisense probe at a concentration of ~200
ng/ml. Sections were then washed three times in 2× SSC and twice for
30 min in 0.2× SSC at 68 °C. After washing, the hybridized probes
were visualized by alkaline phosphatase histochemistry using alkaline
phosphatase-conjugated anti-digoxigenin Fab fragments (Roche Molecular
Biochemicals) and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium.
In Vitro Transcription and Translation--
In vitro
transcription was performed with the mMESSAGE mMACHINETM T7
kit (Ambion Inc., Austin, TX). In vitro translation of the CaT1 protein was performed with the rabbit reticulocyte lysate system
(Promega, Madison, WI) according to the manufacturer's instructions.
Two-microelectrode Voltage Clamp--
The two-microelectrode
voltage clamp experiments were performed following the method described
previously (21) using a commercial amplifier (Clampator One, Model
CA-1B, Dagan Corp., Minneapolis, MN) and pCLAMP software (Version 7, Axon Instruments, Inc., Foster City, CA). An oocyte was introduced into
the chamber containing Ca2+-free solution and was incubated
for ~3 min before being clamped at
50 mV and performing
measurements. In experiments involving voltage ramps or jumps,
whole-cell current and voltage were recorded by digitizing at 300 µs/sample and by Bessel filtering at 10 kHz. When recording currents
at a holding potential, digitization at 0.2 s/sample and filtering at
20 Hz were used. Voltage ramping consisted of pre-holding at
150 mV
for 200 ms to eliminate capacitive currents and a subsequent linear
increase from
150 to +50 mV, with a total duration of 1.4 s.
Voltage jumping consisted of 150-ms voltage pulses of between
140 and
+60 mV, in increments of +20 mV. Steady-state currents were obtained as
the average values in the interval from 135 to 145 ms after the
initiation of the voltage pulses. For experiments involving
voltage-clamped 45Ca2+ uptake,
Ca2+-evoked currents and uptake of
45Ca2+ were simultaneously measured at
50 mV
using a method similar to that described previously (22).
Patch Clamp--
Patch clamp methodology was employed to search
for single channel activities using cell-attached and excised membrane
patches (23). Patch pipettes were prepared from Corning 7052 glass
capillaries (Garner Glass Co.). The pipette tip resistance was 5-10
megaohms. Seal resistances of >10 gigaohms were employed in single
channel experiments, and currents were measured using an integrating
patch clamp amplifier with filtering at 3 kHz through an 8-pole Bessel filter. In cell-attached patches, the resting potential corresponded to
holding the patches at 0 mV. For data acquisition and analysis, voltage
stimuli were applied, and single channel currents were digitized
(50-200 µs/point) and analyzed using a PC, a Digidata Pack, and
programs based on pCLAMP Version 6 (Axon Instruments, Inc.).
 |
RESULTS |
Expression Cloning of CaT1--
The lack of information on the
molecular structure of the intestinal apical calcium transport
protein(s) prompted us to employ the X. laevis oocyte
expression cloning procedure (19) for isolation of cDNA clones.
Oocytes injected with mRNA from rat duodenum or cecum exhibited
reproducible increases in Ca2+ uptake over water-injected
control oocytes. After size fractionation of rat duodenal
poly(A)+ RNA, we detected a substantial increase in
45Ca2+ uptake by injection of RNA from a
2.5-3-kb pool (Fig. 1). A library was
constructed using this RNA pool, and a single clone was isolated from
this size-fractionated cDNA library by screening progressively smaller pools of clones for their ability to induce
45Ca2+ uptake in cRNA-injected oocytes. The
resultant 3-kb cDNA produced large increases in Ca2+
uptake (~30-fold) when expressed in oocytes (Fig. 1). Based on the
properties of the encoded protein, including its saturation kinetics, we named this protein CaT1, for Ca2+
transport protein, subtype 1.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Expression cloning of a calcium transport
protein (CaT1) cDNA. Results are shown for
45Ca2+ uptake by Xenopus oocytes
injected with water, rat duodenal poly(A)+ RNA,
size-fractionated poly(A)+ RNA fraction 18 (2.5-3 kb), or
synthetic cRNA prepared from the cloned CaT1 cDNA. Data represent
the means ± S.E. for groups of 8-10 oocytes.
|
|
Primary Structure of CaT1--
The 2995-base pair CaT1 cDNA
contains an open reading frame of 2181 base pairs that encodes a
protein of 727 amino acid residues with a predicted relative molecular
mass of 83,245 Da (Fig. 2A), which is consistent with the molecular mass obtained by in
vitro translation without microsomes (84 kDa; data not shown).
Hydropathy analysis suggests that CaT1 is a polytopic protein
containing six transmembrane domains (TMs) with an additional short
hydrophobic stretch between TM5 and TM6 (Fig. 2, A and
B). Consistent with the molecular mass of the protein
obtained by in vitro translation in the presence of
microsomes (89 kDa; data not shown), an N-glycosylation site
is predicted in the first extracellular loop of the protein. The
amino-terminal hydrophilic segment (326 amino acid residues) of CaT1
contains four ankyrin repeat domains, suggesting that the protein may
somehow associate with the spectrin-based membrane cytoskeleton (24).
The carboxyl terminus (150 amino acid residues) contains no
recognizable motifs. Putative phosphorylation sites for protein kinases
A and C are present in the cytoplasmic domains (Fig. 2, A
and B), suggesting that transport activity could be regulated by phosphorylation.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 2.
Primary amino acid sequence of CaT1 and its
predicted secondary structure. A, amino acid sequence
of CaT1 encoded by its cDNA. Ankyrin repeat domains are in
gray boxes; transmembrane segments are in black
boxes; and the potential pore region is in the open
box. Putative protein kinase A and C phosphorylation sites and
N-linked glycosylation sites are underlined and
indicated by the star, diamond, and
club, respectively. B, predicted membrane
topology and domain structure of CaT1. Ankyrin repeats are in
gray, and the N-glycosylation site
(branched chains) and the putative protein kinase A
(star) and C (arrows) phosphorylation sites are
marked. Outer and inner leaflets of plasma membrane are indicated.
AA, amino acids.
|
|
CaT1 shows 75% amino acid sequence identity to the recently cloned
rabbit apical epithelial calcium channel ECaC (20) when using the
BESTFIT sequence alignment program. The amino- and carboxyl-terminal cytoplasmic domains of CaT1 from rat and ECaC from rabbit exhibit a
lower degree of similarity than the equivalent regions of rat CaT1 and
partial sequences obtained from human small intestine (data not shown)
by homology screening using the CaT1 cDNA as a probe. Comparisons
of sequences of 150 amino acids in the amino- and carboxyl-terminal
cytoplasmic domains revealed 90 and 74% identities respectively,
between rat and human CaT1, but only 61 and 50% identities,
respectively, between CaT1 and ECaC. CaT1 has four ankyrin repeats and
one protein kinase A phosphorylation site in its amino-terminal
segment, whereas ECaC contains three ankyrin repeats and no protein
kinase A site in the same region. In contrast, ECaC possesses three
protein kinase C sites and two protein kinase A sites in its carboxyl
terminus, whereas CaT1 has only one protein kinase C site and no
protein kinase A sites in the same region. In addition, CaT1 lacks the
putative N-glycosylation site found in ECaC between the pore
region and TM6.
Additional homology searches of available protein data bases revealed
significant similarities between CaT1 and the capsaicin receptor, VR1
(25), and OSM-9, a Caenorhabditis elegans membrane protein
involved in olfaction, mechanosensation, and olfactory adaptation (26).
These proteins are structurally related to the family of putative
store-operated calcium channels (27), among which the first two
identified were the Drosophila retinal proteins TRP (28) and
TRPL (29). Based on the program BESTFIT, CaT1 shows 33.7 and 26.7%
identities to VR1 and OSM-9, respectively, over a stretch of at least
500 residues, as well as 26.2% and 28.9% identities to TRP and TRPL,
respectively, in more restricted regions (residues 552-593 for TRP and
residues 556-593 for TRPL). The latter region covers part of the pore
region and the last transmembrane domain. A common feature of all of
these proteins is the presence of six TMs with a hydrophobic stretch
between TM5 and TM6, resembling one of the four repeated motifs of six TMs in the voltage-gated channels. Another common feature is the presence of three to four ankyrin repeat domains in the cytoplasmic N-terminal region. Of note, members of the polycystin family also possess six transmembrane segments (30-32) and show a modest degree of
homology to CaT1 in small regions of the predicted amino acid sequences
(residues 596-687 in PKD2, 23% identity; and residues 381-483 in
PKD2L, 26% identity), but the polycystins contain no ankyrin repeats.
A homology search using the CaT1 sequence in expressed sequence tag
data bases revealed the following GenBankTM sequences with
high degrees of similarity to CaT1 (percent identities refer to
nucleotide identities): GenBankTM accession number AI101583
from rat brain (99%); AI007094 from mouse thymus (96%); AA447311,
AA469437, and AA579526 from human prostate (87, 85, and 84%,
respectively), W88570 from human fetal liver spleen (91%); AA078617
from human brain (85%); and T92755 from human lung (92%).
Tissue Distribution of CaT1--
Northern analysis of rat tissues
revealed a strong 3.0-kb band in rat small intestine and a weaker
6.5-kb band in brain, thymus, and adrenal gland (Fig.
3A). No CaT1 transcripts were
detected in heart, kidney, liver, lung, spleen, and skeletal muscle.
Northern analysis of the gastrointestinal tract revealed that the 3-kb CaT1 transcript is expressed in duodenum, proximal jejunum, cecum, and
colon, but not in stomach, distal jejunum, or ileum (Fig. 3B). The CaT1 mRNA in rat duodenum was not regulated by
1,25-dihydroxyvitamin D3 or by calcium deficiency in
vivo (Fig. 3C).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 3.
Northern analysis of tissue distribution of
CaT1 mRNA and effects of 1,25-dihydroxyvitamin D3 and
calcium deficiency on duodenal mRNA levels. A,
evaluation of tissue distribution of CaT1 mRNA by Northern
analysis. Each lane was loaded with 3 µg of poly(A)+ RNA
from the indicated adult rat tissues. B, Northern analysis
of CaT1 mRNA in gastrointestinal tract. Each lane was loaded with 3 µg of poly(A)+ RNA from stomach (lane 1),
duodenum and proximal jejunum (~20 cm from stomach) (lane
2), the rest of the jejunum (lane 3), ileum (lane
4), cecum (lane 5), and colon (lane 6).
C, CaT1 mRNA expression is not regulated by
1,25-dihydroxyvitamin D3 or calcium deficiency in duodenum.
Lane 1, 2 µg of poly(A)+ RNA from normal rats
(pooled RNA from five rats); lane 2, pooled
poly(A)+ RNA from 1,25-dihydroxyvitamin
D3-treated rats (duodenal mRNA was isolated from five
rats 15 h after injection with 1 µg of 1,25-dihydroxyvitamin
D3); lane 3, pooled poly(A)+ RNA
from calcium-deficient rats. 10 rats were fed a calcium-deficient diet
and MilliQ water for 2 weeks before sacrifice. The same blot was also
hybridized with a 32P-labeled rat
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA
fragment as a control.
|
|
In situ hybridization revealed expression of CaT1 mRNA
in the absorptive epithelial cells of duodenum, proximal jejunum,
cecum, and colon, but not in ileum (Fig.
4). CaT1 mRNA is expressed at high
levels in duodenum and cecum, at lower levels in proximal jejunum, and
at very low levels in colon. In all CaT1-expressing intestinal
segments, mRNA levels are higher at the villi tips than in the
villi crypts (Fig. 4, A, B, and D). No
signals were detected in kidney under the same experimental conditions
or in sense controls.

View larger version (113K):
[in this window]
[in a new window]
|
Fig. 4.
CaT1 mRNA distribution in rat intestine
detected by in situ hybridization. Shown are
bright-field micrographs of cryosections hybridized to a
digoxigenin-labeled CaT1 antisense cRNA probe. A, duodenum
(M, muscle layer; V, villi; C, crypt;
L, lumen). CaT1 is expressed in enterocytes lining the
villi, with the highest mRNA concentrations at the villi tips.
B, jejunum (proximal). CaT1 is expressed only at the villi
tips (arrows). C, ileum. D, cecum.
CaT1 is strongly expressed in enterocytes. E, colon. Weak
CaT1 labeling is present in the surface epithelial cells
(arrows). The bar denotes 100 µm.
|
|
Characterization of Functional Properties of CaT1 by
45Ca2+ Uptake Assay--
Since CaT1 shares
similarity in its structure with the capsaicin receptor (VR1) (25) and
TRP (transient receptor potential) and TRPL (TRP-like) channels (28, 29, 33), we
tested the possibility that the activity of CaT1 could be stimulated by
capsaicin or calcium store depletion. Capsaicin (up to 50 µM) did not stimulate CaT1-mediated
45Ca2+ uptake in oocytes (data not shown).
Instead of stimulating Ca2+ entry, depletion of calcium
stores by thapsigargin treatment decreased CaT1-mediated
Ca2+ activity to ~20% of its base-line activity (Fig.
5A). Based on these data, it
is unlikely that CaT1 is another subtype of capsaicin-gated or
store-operated ion channels.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 5.
Characterization of CaT1 by
45Ca2+ uptake assay. A,
CaT1-mediated Ca2+ uptake is not stimulated by calcium
store depletion. Calcium store depletion by thapsigargin treatment (2 µM in 0.025% Me2SO for >3 h in
Ca2+-free modified Barth's solution) was performed as
described (51). Control experiments were performed in the same solution
without thapsigargin. Black bars, CaT1-injected oocytes;
gray bars, water-injected oocytes; white
bars, difference between the two. B,
concentration-dependent Ca2+ uptake mediated by
CaT1. Uptakes were performed at varying Ca2+ concentrations
(0.02-5 mM) with CaT1 cRNA- and water-injected oocytes.
C, Na+ and Cl dependence of
CaT1-mediated Ca2+ uptake. Uptakes were performed with
standard medium, sodium-free medium in which NaCl was substituted by
choline chloride (Cho-Cl), or low Cl (4 mM) medium in which NaCl was substituted by sodium
cyclamate (Na-Cyc). D, pH effect on CaT1-mediated
Ca2+ uptake. Uptake was performed in standard uptake
solution with varying pH. Data shown were obtained by subtracting the
uptake by water-injected oocytes under the same experimental condition.
E, CaT1-mediated Ca2+ uptake is inhibitable by
divalent and trivalent metal ions. Uptakes were performed in the
presence of Mg2+, Sr2+, or Ba2+ at
10 mM or other metal ions at 100 µM in
standard uptake solution with 1 mM Ca2+.
Fe2+ was maintained in solution with 1 mM
L-ascorbic acid, which had no effect on Ca2+
uptake. Fe II and Fe III represent
Fe2+ and Fe3+, respectively. Gadolinium and
lanthanum are in their trivalent forms, and other metals are in their
divalent forms. All metal ions were prepared from their chloride
salts.
|
|
When expressed in oocytes, CaT1-mediated 45Ca2+
uptake was linear for up to 2 h (data not shown). Ca2+
uptake was concentration-dependent and saturable, with an
apparent Michaelis constant (Km) of 0.44 ± 0.07 mM (Fig. 5B). This Km is
appropriate for absorbing Ca2+ from the intestine, which is
normally ~1-5 mM after a calcium-containing meal.
Consistent with the prediction from early studies that apical Ca2+ uptake is not energy-dependent,
CaT1-mediated transport did not appear to be coupled to
Na+, Cl
, or H+ (Fig. 5,
C and D). To study the substrate specificity of
CaT1, we initially performed inhibition studies of
45Ca2+ uptake (1 mM
Ca2+) by various di- and trivalent cations (100 µM) (Fig. 5E). Gd3+,
La3+, Cu2+, Pb2+, Cd2+,
Co2+, and Ni2+ produced marked to moderate
inhibition, whereas Fe2+, Fe3+,
Mn2+, and Ni2+ had no significant effects. In
contrast, Ba2+ and Sr2+ had only slight
inhibitory effects, even at a concentration of 10 mM,
whereas Mg2+ (10 mM) produced no significant
inhibition (Fig. 5E).
Ca2+ entry into enterocytes has, in general, been reported
to be insensitive to classic voltage-dependent calcium
channel blockers and to be only slightly inhibited by verapamil (17,
18). Among the three classes of L-type calcium channel blockers that we
tested (nifedipine, diltiazem, and verapamil), only the latter two
modestly inhibited CaT1-mediated Ca2+ uptake (by 10-15%)
at relatively high concentrations (10-100 µM) (data not shown).
Electrophysiological Properties of CaT1-mediated
Transport--
External application of Ca2+ to oocytes
expressing CaT1 generated inward currents at a holding potential of
50 mV (Fig. 6A, left
panel), which were absent in control oocytes (data not shown). Addition of 5 mM Ca2+ evoked an overshoot of
inward current to several hundred nA, followed by a rapid reduction to
a plateau value of 20-50 nA (Fig. 6A, left
panel). CaT1-mediated current was also
voltage-dependent, as revealed by current-voltage
(I-V) curves (Fig. 6A, right
panel). The peak current (curve 2) is due to endogenous
Ca2+-activated chloride channel currents (34) because it
could be blocked by chloride channel (curve 3) blockers such
as flufenamate (data not shown). The plateau also contained
flufenamate-inhibitable currents, suggesting that some endogenous,
Ca2+-activated chloride channels remained active during
this phase. Chelating intracellular Ca2+ by injection of
EGTA into oocytes expressing CaT1 to a final concentration of 1-2
mM resulted in a 3-5-fold increase in Ca2+
uptake (data not shown) and abolished the overshoot of the current (Fig. 6B, left panel). Under the same condition,
EGTA-injected control oocytes produced no detectable currents.
Therefore, CaT1 likely mediates the observed
Ca2+-evoked currents in EGTA-injected oocytes (Fig.
6B).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Ca2+-evoked currents in oocytes
expressing CaT1. A, currents recorded before and after
Ca2+ addition in an oocyte expressing CaT1. Left
panel, inward current elicited by application of 5 mM
Ca2+ at a holding potential of 50 mV; right
panel, I-V curves obtained at the times
indicated in the left panel, using a voltage ramp protocol
as illustrated. B, currents recorded in an EGTA-injected
oocyte expressing CaT1. Oocytes were injected with 25 nl of 50 mM EGTA at least 2 h prior to measurements. Left
panel, inward current due to addition of 5 mM
Ca2+ at 50 mV; right panel,
I-V curves obtained before and after
Ca2+ addition.
|
|
In the absence of Ca2+, oocytes expressing CaT1 exhibited a
significant permeability to Na+ at hyperpolarized
potentials (Fig. 7A). Similar
conductances were observed for K+, Rb+, and
Li+ (K+
Rb+ > Na+ > Li+) (data not shown). CaT1-mediated permeation of
monovalent cations exhibited inward rectification because the sum of
endogenous K+ and Na+ concentrations is high in
Xenopus oocytes. In addition, Ca2+-evoked
currents were slightly lower in the presence of 100 mM Na+ than in its absence (Fig. 7B), presumably
due to the presence of modest competition between Ca2+ and
Na+ for permeation via CaT1. Interestingly, with prolonged
application of Ca2+ (30 min) to non-clamped oocytes
expressing CaT1, Ca2+ entry was enhanced by extracellular
Na+ (Fig. 5C). Further studies are needed to
fully elucidate the mechanisms underlying the effects of
Na+ on Ca2+ transport.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
Na+ effects on oocytes expressing
CaT1. A, comparison of total conductance between
water-injected oocytes and oocytes expressing CaT1 in the presence of
standard uptake solution and in the absence of extracellular
Ca2+. Shown are average I-V curves
obtained from control (n = 12) or CaT1-expressing
(n = 28) oocytes following voltage jumps from the
holding level of 50 mV to the final potentials, which ranged between
140 and +60 mV. B, currents due to addition of 5 mM Ca2+ in the presence or absence of
extracellular Na+ at 50 mV. CaT1-expressing oocytes were
pre-injected with EGTA. Cho, choline chloride.
|
|
To determine whether Ca2+ entry via CaT1 is associated with
influx or efflux of other ions, the
charge/45Ca2+ influx ratio was determined in
voltage-clamped oocytes pre-injected with EGTA (Fig.
8A). In the absence of
external Na+, the calculated ratio was not significantly
different from 2 (Fig. 8B), indicating that permeation of
Ca2+ alone accounts for the observed inward currents.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Charge/Ca2+-uptake ratio of
CaT1-mediated Ca2+ transport.
Ca2+-elicited inward current and
45Ca2+ influx were measured simultaneously
under voltage clamp (Vh = 50 mV). A,
shown is a representative example of currents generated by 2 mM Ca2+ (cold + hot) in an EGTA-injected,
CaT1-expressing oocyte in the presence of an external solution
containing 100 mM choline chloride. The charge moved was
calculated by integrating the Ca2+-evoked current over the
uptake period and converting into picomoles. B, a mean
charge/Ca2+ uptake ratio of 1.90 ± 0.15 (n = 5) was obtained.
|
|
Despite their weak inhibitory potencies, Ba2+ and
Sr2+ (but not Mg2+) evoked CaT1-specific
currents, albeit with much smaller amplitudes (Fig.
9). In EGTA-injected oocytes expressing
CaT1 that were clamped at
50 mV, currents due to addition of 5 mM Ba2+ and Sr2+ represented
12 ± 2 and 20 ± 4% (n = 17), respectively,
of the current evoked by 5 mM Ca2+. No
significant Sr2+- or Ba2+-evoked currents were
observed in control oocytes under similar conditions. Other divalent
metal ions, including Fe2+, Mn2+,
Zn2+, Co2+, Ni2+, Cu2+,
Pb2+, and Cd2+, and the trivalent metal ions
Fe3+, La3+, and Gd3+ (each at 100 µM) did not evoke measurable currents when applied to
oocytes expressing CaT1 (data not shown). In agreement with their
inhibitory effects on 45Ca2+ uptake (Fig.
4E), Gd3+, La3+, Cu2+,
Pb2+, Cd2+, Co2+, and
Ni2+ (each at 100 µM) all inhibited the
Ca2+-evoked currents, whereas the same concentration of
Fe3+, Mn2+, and Zn2+ had no
observable effects (data not shown). Magnesium is neither a substrate
(up to 20 mM) nor an effective blocker of CaT1.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9.
Sr2+ and Ba2+ (but
not Mg2+) are substrates of CaT1. Shown is a
comparison of currents evoked by Ca2+, Ba2+,
Sr2+, and Mg2+ (each at 5 mM) at
50 mV in an oocyte expressing CaT1 (top) and in a
water-injected oocyte (bottom). Oocytes were injected with
EGTA 2 h before measurements.
|
|
Single channel activities were sought in CaT1-expressing oocytes using
the cell-attached and excised patch configurations of the patch clamp
technique. No CaT1-specific channel activities could be identified that
were clearly distinguishable from the endogenous channels present in
control oocytes, based on studies of 52 patches from 46 oocytes (EGTA-
or non-EGTA-injected) obtained from seven frogs. Further studies are
needed to determine whether CaT1-specific single channel activity can
be identified under appropriate experimental conditions.
 |
DISCUSSION |
Despite extensive studies of intestinal Ca2+
absorption, the protein that mediates Ca2+ entry in the
transcellular pathway has remained elusive. A calcium channel with a
structure similar to that of CaT1 has recently been isolated from
rabbit kidney that exhibits an apical localization in the epithelial
cells of the distal tubule (20). CaT1, which was cloned from rat
duodenum, exhibits the characteristic expression pattern and functional
properties of the previously described intestinal Ca2+
uptake mechanism. By measuring mucosa-to-serosa calcium transport across short-circuited rat intestinal segments, a saturable pathway has
been identified in duodenum and jejunum (35) and cecum (36). The latter
is the site with the highest transcellular calcium absorption in rat
intestine (36). The mRNA distribution pattern of CaT1 in rat
intestine (Figs. 3 and 4) shows the highest levels in cecum and
duodenum and thereby closely matches the results describing segmental
heterogeneity of intestinal transcellular calcium absorption (35-39).
The ankyrin repeats predicted from the deduced amino acid sequence of
CaT1 suggest that it may be associated with cytoskeletal proteins
supporting the microvilli at the apical poles of the absorptive cells
in the intestine (24). The 6.5-kb CaT1 transcript detected in brain,
thymus, and adrenal gland and the presence of expressed sequence tags
in rat and human brain and human prostate, fetal liver spleen,
placenta, and lung suggest that CaT1 or a similar protein(s) plays
additional roles beyond intestinal calcium absorption.
The apparent affinity constant for CaT1-mediated Ca2+
uptake in Xenopus oocytes of 0.44 mM is in the
range of the values previously reported by other investigators in
physiological studies of calcium absorption in rat (37-39), hamster
(39), pig (40), and human (41, 42) intestines. In agreement with
previous predictions (10, 15, 16), CaT1-mediated Ca2+
transport is driven by the electrochemical gradient of
Ca2+. There is no evidence for coupling of
Ca2+. uptake to other ions or to metabolic energy. Although
CaT1-mediated Ca2+ transport is electrogenic and
voltage-dependent, its kinetic behavior is distinct from
that of the voltage-dependent calcium channels, which are
operated by membrane voltage. At a macroscopic level, the kinetic
properties of CaT1 resemble those of a facilitated transporter, and our
patch clamp studies have not as yet provided any evidence for distinct
single channel activity. CaT1 may represent an evolutionary transition
between a channel and a facilitated transporter.
CaT1 is rather specific for Ca2+, showing only moderate
abilities to transport Sr2+ and Ba2+. Our
results provide a molecular basis for the widespread use of stable
isotopes of strontium as a surrogate for monitoring intestinal
absorption of calcium, as performed recently in human subjects (43,
44). Mg2+ does not appear to be a substrate for CaT1, in
agreement with results reported previously (45). The inhibitory effects
on CaT1-mediated Ca2+ uptake exerted by other metal ions,
such as Cd2+ and Pb2+, provide a potential
mechanistic basis for understanding the interactions of various metal
ions during intestinal absorption (46).
It is a puzzle why CaT1 shows higher activities at alkaline than at
acidic pH, despite being exposed to an acidic environment in the upper
duodenal lumen in vivo. However, a decrease in calcium absorption in rat duodenum at reduced levels of pH has been reported previously (47). It is well known that the milk-alkali syndrome was
once a relatively common cause of hypercalcemia as a result of
aggressive treatment of peptic ulcer disease with milk and antacids (3,
4, 48), perhaps due to increased CaT1-mediated Ca2+ uptake
at alkaline pH. Ca2+ is transported bidirectionally
(mucosa-to-serosa and serosa-to-mucosa) in the small intestine.
Secreted Ca2+ can be absorbed more distally in the large
intestine, which has a higher luminal pH. Considering the length,
sojourn time, and intraluminal pH in rat duodenum (8 cm, 3 min, and pH
6.6, respectively) (49), cecum (4 cm, 92 min, and pH 7.6) (50), and
colon (14 cm, 92 min, and pH 7.0) (50), it is likely that the increased luminal pH in cecum and colon enhances the ability of these segments in
Ca2+ absorption. A study using human colonic apical
membrane vesicles has provided evidence that a similar mechanism for
Ca2+ uptake exists in human colon (42), which exhibits
apparent Michaelis constants of 0.51 ± 0.05 and 0.42 ± 0.04 mM in the proximal and distal colon, respectively, which
are close to that for CaT1 (0.44 ± 0.07 mM).
The duodenal mRNA level of CaT1 was not responsive to
1,25-dihydroxyvitamin D3 administration or to a
calcium-deficient diet in rats in vivo, which is in
agreement with previous studies demonstrating that apical entry of
Ca2+ is not substantially regulated by vitamin D (17, 37).
However, because the overall transcellular absorption of calcium is
regulated by vitamin D (and this includes regulation of the
synthesis of calbindin D9K) (10-12), CaT1 activity would
be expected to be regulated directly or indirectly by the vitamin D
and/or calcium status of the organism to prevent toxic accumulation of
intracellular Ca2+. The presence of multiple putative
protein kinase A and C phosphorylation sites in CaT1 may suggest
phosphorylation-dependent regulation. In addition, the findings
that EGTA injection increases CaT1 activity and that the calcium-evoked
current decays upon prolonged calcium application (Fig. 8) suggest that
CaT1 is controlled by a feedback regulatory mechanism, possibly through
interaction of intracellular calcium with the transporter. The
mechanisms underlying these phenomena need to be studied further.
CaT1 shares structural similarity (75% identity) with the epithelial
calcium channel ECaC from rabbit kidney (20). There are numerous
differences between the two proteins, in particular with respect to the
amino- and carboxyl-terminal cytoplasmic domains (which are
considerably more conserved between rat and human CaT1 than between
CaT1 and ECaC), the number of ankyrin repeats, the number and
distribution of protein kinase A and C phosphorylation sites, and their
N-glycosylation sites. CaT1 and ECaC exhibit functional
similarities with respect to saturation kinetics (Km for Ca2+ = 0.44 and 0.2 mM, respectively) and
pH sensitivity. However, more studies on ECaC are required to fully
evaluate the differences between the two proteins in terms of the
substrate specificities, the effects of Na+ on their
activities, and regulation by intracellular Ca2+, etc.
Moreover, additional investigation is needed to document that CaT1 and
ECaC are the products of different genes as opposed to being splice
variants in a given species.
A striking difference between CaT1 and ECaC is that ECaC is abundant in
the distal tubules and cortical collecting duct of rabbit kidney (20),
whereas the CaT1 mRNA was undetectable in rat kidney, based on
Northern analysis and in situ hybridization. Although the
transcellular absorption of calcium in the intestine and its
reabsorption in kidney share certain similarities (9), many differences
also exist. For instance, different 1,25-dihydroxyvitamin D3-regulated calcium-binding proteins (calbindins
D9K and D28K, respectively) are present in the
intestine and kidney. Therefore, it is not too surprising that
different calcium-absorptive proteins exist in the intestine and kidney.
CaT1 also shows moderate similarity to the capsaicin receptor, VR1,
which is a ligand-gated, nonselective cation channel (25) and is
structurally related to members of the TRP family of channels, some of
which are operated by calcium store depletion (27, 33). However, CaT1
does not appear to be a ligand-gated channel since its open state does
not require ligand binding. In contrast to channels opened by calcium
store depletion, CaT1 activity is down-regulated in association with
calcium store depletion.
Alterations in calcium absorption are present in many physiological and
pathological states (3). Increased absorption occurs during pregnancy
and lactation as well as in pathological states such as sarcoidosis and
other granulomatous disorders, primary hyperparathyroidism, diabetes,
idiopathic hypercalciuric syndromes, and phosphorus depletion.
Increased calcium absorption can also be induced pharmacologically as
in milk-alkali syndrome and by vitamin D intoxication, estrogens, and
non-absorbable antacids. It will be of considerable interest to
determine whether CaT1 contributes to the excessive absorption of
calcium present in one or more of these states. Malabsorption of
calcium is a common feature of aging and can contribute to
osteoporosis. Moreover, pathological states such as intrinsic bowel
disease, hepatobiliary disease, renal disease, hyperthyroidism, and
hypoparathyroidism are also associated with calcium malabsorption. The
cloning and characterization of the calcium transporter CaT1 may
provide a molecular basis for achieving a better understanding of
calcium malabsorption in such states as well as the regulation of
intestinal calcium absorption under more normal physiological conditions.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Paola Marciani for
help with RNA size fractionation, Dr. Zhi-Lin Liu for help with
in vitro translation of CaT1, and Drs. Alan Shiu Leun Yu and
R. John MacLeod for valuable discussions.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants DK41415, DK48330, and DK52005 (to M. A. H. and
E. M. B.) and by grants from the St. Giles Foundation (to E. M. B. and P. M. V.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF160798.
¶
Recipient of a Brigham and Women's Hospital dual-mentored fellowship.
Recipient of long-term fellowship from the International Human
Frontier Science Program.

To whom correspondence should be addressed: Harvard Institutes
of Medicine, Rm. 570, 77 Ave. Louis Pasteur, Boston, MA 02115. E-mail:
mhediger@rics.bwh.harvard.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
kb, kilobase(s);
TM, transmembrane domain.
 |
REFERENCES |
| 1.
|
Brown, E. M.
(1991)
Physiol. Rev.
71,
371-411[Free Full Text]
|
| 2.
|
Bronner, F.
(1997)
in
Handbook of Nutritionally Essential Mineral Elements
(O'Dell, B. L.
, and Sunde, R. A., eds)
, pp. 13-66, Marcel Dekker, Inc., New York
|
| 3.
|
Birge, S. J.,
and Avioli, L. V.
(1987)
in
Clinical Disorders of Membrane Transport Processes
(Andreoli, T. E.
, Hoffman, J. F.
, Fanestil, D. D.
, and Schultz, S. G., eds)
, pp. 121-140, Plenum Press, New York
|
| 4.
|
Schron, C. M.
(1995)
in
Textbook of Gastroenterology
(Yamada, T., ed)
, pp. 467-484, J. B. Lippincott Co., Philadelphia
|
| 5.
|
Bronner, F.,
Pansu, D.,
and Stein, W. D.
(1986)
Am. J. Physiol.
250,
G561-G569[Abstract/Free Full Text]
|
| 6.
|
Buckley, M.,
and Bronner, F.
(1980)
Arch. Biochem. Biophys.
202,
235-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Pansu, D.,
Duflos, C.,
Bellaton, C.,
and Bronner, F.
(1993)
J. Nutr.
123,
1396-1404
|
| 8.
|
Bronner, F.
(1991)
Int. Rev. Cytol.
131,
169-212[Medline]
[Order article via Infotrieve]
|
| 9.
|
Kumar, R.
(1995)
J. Cell. Biochem.
57,
392-398[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Wasserman, R. H.,
and Fullmer, C. S.
(1995)
J. Nutr.
125,
1971S-1979S
|
| 11.
|
Feher, J. J.,
Fullmer, C. S.,
and Wasserman, R. H.
(1992)
Am. J. Physiol.
262,
C517-C526[Abstract/Free Full Text]
|
| 12.
|
Wasserman, R. H.,
and Taylor, A. N.
(1966)
Science
152,
791-793[Abstract/Free Full Text]
|
| 13.
|
Ghijsen, W. E.,
van Os, C. H.,
Heizmann, C. W.,
and Murer, H.
(1986)
Am. J. Physiol.
251,
G223-G229
|
| 14.
|
Wasserman, R. H.,
Chandler, J. S.,
Meyer, S. A.,
Smith, C. A.,
Brindak, M. E.,
Fullmer, C. S.,
Penniston, J. T.,
and Kumar, R.
(1992)
J. Nutr.
122,
662-671
|
| 15.
|
Stein, W. D.
(1992)
J. Nutr.
122,
651-656
|
| 16.
|
Holdsworth, E. S.
(1965)
Biochem. J.
96,
475-483[Medline]
[Order article via Infotrieve]
|
| 17.
|
Favus, M. J.,
and Angeid-Backman, E.
(1985)
Am. J. Physiol.
248,
G676-G681
|
| 18.
|
Fox, J.,
and Green, D. T.
(1986)
Eur. J. Pharmacol.
129,
159-164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Romero, M. F.,
Kanai, Y.,
Gunshin, H.,
and Hediger, M. A.
(1998)
Methods Enzymol.
296,
17-52[Medline]
[Order article via Infotrieve]
|
| 20.
|
Hoenderop, J. G.,
van der Kemp, A. W.,
Hartog, A.,
van de Graaf, S. F.,
Van Os, C. H.,
Willems, P. H.,
and Bindels, R. J.
(1999)
J. Biol. Chem.
274,
8375-8378[Abstract/Free Full Text]
|
| 21.
|
Chen, X. Z.,
Shayakul, C.,
Berger, U. V.,
Tian, W.,
and Hediger, M. A.
(1998)
J. Biol. Chem.
273,
20972-20981[Abstract/Free Full Text]
|
| 22.
|
Chen, X. Z.,
Zhu, T.,
Smith, D. E.,
and Hediger, M. A.
(1999)
J. Biol. Chem.
274,
2773-2779[Abstract/Free Full Text]
|
| 23.
|
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Pflüegers Arch. Eur. J. Physiol.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Bennett, V.,
and Gilligan, D. M.
(1993)
Annu. Rev. Cell Biol.
9,
27-66[CrossRef]
|
| 25.
|
Caterina, M. J.,
Schumacher, M. A.,
Tominaga, M.,
Rosen, T. A.,
Levine, J. D.,
and Julius, D.
(1997)
Nature
389,
816-824[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Colbert, H. A.,
Smith, T. L.,
and Bargmann, C. I.
(1997)
J. Neurosci.
17,
8259-8269[Abstract/Free Full Text]
|
| 27.
|
Birnbaumer, L.,
Zhu, X.,
Jiang, M.,
Boulay, G.,
Peyton, M.,
Vannier, B.,
Brown, D.,
Platano, D.,
Sadeghi, H.,
Stefani, E.,
and Birnbaumer, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15195-15202[Abstract/Free Full Text]
|
| 28.
|
Montell, C.,
and Rubin, G. M.
(1989)
Neuron
2,
1313-1323[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Phillips, A. M.,
Bull, A.,
and Kelly, L. E.
(1992)
Neuron
8,
631-642[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Mochizuki, T.,
Wu, G.,
Hayashi, T.,
Xenophontos, S. L.,
Veldhuisen, B.,
Saris, J. J.,
Reynolds, D. M.,
Cai, Y.,
Gabow, P. A.,
Pierides, A.,
Kimberling, W. J.,
Breuning, M. H.,
Deltas, C. C.,
Peters, D. J.,
and Somlo, S.
(1996)
Science
272,
1339-1342[Abstract]
|
| 31.
|
Nomura, H.,
Turco, A. E.,
Pei, Y.,
Kalaydjieva, L.,
Schiavello, T.,
Weremowicz, S.,
Ji, W.,
Morton, C. C.,
Meisler, M.,
Reeders, S. T.,
and Zhou, J.
(1998)
J. Biol. Chem.
273,
25967-25973[Abstract/Free Full Text]
|
| 32.
|
Wu, G.,
Hayashi, T.,
Park, J. H.,
Dixit, M.,
Reynolds, D. M.,
Li, L.,
Maeda, Y.,
Cai, Y.,
Coca-Prados, M.,
and Somlo, S.
(1998)
Genomics
54,
564-568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Gillo, B.,
Chorna, I.,
Cohen, H.,
Cook, B.,
Manistersky, I.,
Chorev, M.,
Arnon, A.,
Pollock, J. A.,
Selinger, Z.,
and Minke, B.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14146-14151[Abstract/Free Full Text]
|
| 34.
|
Dascal, N.
(1987)
CRC Crit. Rev. Biochem.
22,
317-387[Medline]
[Order article via Infotrieve]
|
| 35.
|
Karbach, U.
(1991)
Gastroenterology
100,
47-58[Medline]
[Order article via Infotrieve]
|
| 36.
|
Karbach, U.,
and Feldmeier, H.
(1993)
Dig. Dis. Sci.
38,
1815-1824[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Miller, A., III,
and Bronner, F.
(1981)
Biochem. J.
196,
391-401[Medline]
[Order article via Infotrieve]
|
| 38.
|
Wilson, H. D.,
Schedl, H. P.,
and Christensen, K.
(1989)
Am. J. Physiol.
257,
F446-F453[Abstract/Free Full Text]
|
| 39.
|
Schedl, H. P.,
and Wilson, H. D.
(1985)
J. Clin. Invest.
76,
1871-1878
|
| 40.
|
Kaune, R.,
Kassianoff, I.,
Schroder, B.,
and Harmeyer, J.
(1992)
Biochim. Biophys. Acta
1109,
187-194[Medline]
[Order article via Infotrieve]
|
| 41.
|
Ghishan, F. K.,
Arab, N.,
and Nylander, W.
(1989)
Gastroenterology
96,
122-129[Medline]
[Order article via Infotrieve]
|
| 42.
|
Elsharydah, A.,
Syed, R.,
Tyagi, S.,
Khudeira, A. K.,
Harig, J. M.,
and Dudeja, P. K.
(1995)
Gastroenterology
109,
876-884[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Vezzoli, G.,
Baragetti, I.,
Zerbi, S.,
Caumo, A.,
Soldati, L.,
Bellinzoni, P.,
Centemero, A.,
Rubinacci, A.,
Moro, G.,
and Bianchi, G.
(1998)
Clin. Chem.
44,
586-590[Abstract/Free Full Text]
|
| 44.
|
Vezzoli, G.,
Caumo, A.,
Baragetti, I.,
Zerbi, S.,
Bellinzoni, P.,
Centemero, A.,
Rubinacci, A.,
Moro, G.,
Adamo, D.,
Bianchi, G.,
and Soldati, L.
(1999)
Clin. Chem.
45,
257-261[Abstract/Free Full Text]
|
| 45.
|
Karbach, U.,
Schmitt, A.,
and Saner, F. H.
(1991)
Dig. Dis. Sci.
36,
1611-1618[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Goyer, R. A.
(1997)
Annu. Rev. Nutr.
17,
37-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Favus, M. J.,
Bushinsky, D. A.,
and Coe, F. L.
(1986)
Am. J. Physiol.
251,
G695-G700
|
| 48.
|
Burnett, C. H.,
Commons, R. R.,
Albright, F.,
and Howard, J. E.
(1949)
N. Engl. J. Med.
240,
787-794[Medline]
[Order article via Infotrieve]
|
| 49.
|
Duflos, C.,
Bellaton, C.,
Pansu, D.,
and Bronner, F.
(1995)
J. Nutr.
125,
2348-2355
|
| 50.
|
Bronner, F.,
and Pansu, D.
(1999)
J. Nutr.
129,
9-12[Abstract/Free Full Text]
|
| 51.
|
Yao, Y.,
and Tsien, R. Y.
(1997)
J. Gen. Physiol.
109,
703-715[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K.-S. Min, H. Ueda, T. Kihara, and K. Tanaka
Increased Hepatic Accumulation of Ingested Cd is Associated with Upregulation of Several Intestinal Transporters in Mice Fed Diets Deficient in Essential Metals
Toxicol. Sci.,
November 1, 2008;
106(1):
284 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|